Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

July 31, 2016

Conditions
Anus NeoplasmsHIV Infections
Interventions
PROCEDURE

Argon Plasma Coagulation

Argon Plasma Coagulation (APC) is a non-contact electrosurgical technique delivering a high-frequency electrical current through ionized argon gas i.e. the argon plasma. This current produces a zone of coagulation, desiccation, and devitalisation 2-3 mm deep. Patients will be offered up to 3 treatments if recurrence occur after the first two.

Trial Locations (2)

H2L 4M1

Notre-Dame Hospital (Centre Hospitalier de l'Université de Montréal), Montreal

H2X 2P4

Royal Victoria Hospital (McGill University Health Center), Montreal

All Listed Sponsors
collaborator

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

collaborator

CIHR Canadian HIV Trials Network

NETWORK

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT00428285 - Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men | Biotech Hunter | Biotech Hunter